TY - JOUR
T1 - Clinical, imaging and genetic profile of twenty-four patients with pantothenate kinase-associated neurodegeneration (PKAN)- A single centre study from India
AU - Sriram, Neeharika
AU - Holla, Vikram V.
AU - Kumari, Riyanka
AU - Kamble, Nitish
AU - Saini, Jitender
AU - Mahale, Rohan
AU - Netravathi, Manjunath
AU - Padmanabha, Hansashree
AU - Gowda, Vykuntaraju K.
AU - Battu, Rajani
AU - Pandey, Akhilesh
AU - Yadav, Ravi
AU - Muthusamy, Babylakshmi
AU - Pal, Pramod Kumar
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/6
Y1 - 2023/6
N2 - Introduction: Pantothenate kinase-associated neurodegeneration (PKAN) is the most common “Neurodegeneration with Brain Iron Accumulation” disorder. This study aimed to study the clinical, radiological and genetic profiling of a large cohort of patients with PKAN. Methods: This is an ambispective hospital-based single centre study conducted at a tertiary care centre from India. After tabulating the clinical details, appropriate rating scales were applied followed by magnetic resonance imaging brain and exome sequencing. The segregation of the causal variants in the families were analysed using Sanger sequencing. Results: Twenty-four patients (14 males) with a median age at initial examination of 13 years (range: 4–54 years) and age at onset of 8 years (range: 0.5–40 years) were identified. Almost two-thirds (62%) had onset before 10 years. Difficulty walking was the most common presenting symptom (41.6%) and dystonia was the most common extrapyramidal phenomenology (100%) followed by parkinsonism (54.2%). Retinitis pigmentosa was present in 37.5% patients. MRI showed hypo intensity on T2 and SWI sequences in globus pallidus (100%), substantia nigra (70.8%) and red nucleus (12.5%). Eye-of-the-tiger sign was present in 95.8%. Biallelic variants in PANK2 gene was identified in all 20 patients who underwent genetic testing. Among the 18 unique variants identified in these 20 patients 10 were novel. Sanger sequencing confirmed the segregation of the mutation in the available family members. Conclusions: Wide range of age at onset was noted. Dystonia at presentation, pathognomonic eye-of-tiger sign, and disease-causing variants in PANK2 gene were identified in nearly all patients. Ten novel variants were identified expanding the genotypic spectrum of PKAN.
AB - Introduction: Pantothenate kinase-associated neurodegeneration (PKAN) is the most common “Neurodegeneration with Brain Iron Accumulation” disorder. This study aimed to study the clinical, radiological and genetic profiling of a large cohort of patients with PKAN. Methods: This is an ambispective hospital-based single centre study conducted at a tertiary care centre from India. After tabulating the clinical details, appropriate rating scales were applied followed by magnetic resonance imaging brain and exome sequencing. The segregation of the causal variants in the families were analysed using Sanger sequencing. Results: Twenty-four patients (14 males) with a median age at initial examination of 13 years (range: 4–54 years) and age at onset of 8 years (range: 0.5–40 years) were identified. Almost two-thirds (62%) had onset before 10 years. Difficulty walking was the most common presenting symptom (41.6%) and dystonia was the most common extrapyramidal phenomenology (100%) followed by parkinsonism (54.2%). Retinitis pigmentosa was present in 37.5% patients. MRI showed hypo intensity on T2 and SWI sequences in globus pallidus (100%), substantia nigra (70.8%) and red nucleus (12.5%). Eye-of-the-tiger sign was present in 95.8%. Biallelic variants in PANK2 gene was identified in all 20 patients who underwent genetic testing. Among the 18 unique variants identified in these 20 patients 10 were novel. Sanger sequencing confirmed the segregation of the mutation in the available family members. Conclusions: Wide range of age at onset was noted. Dystonia at presentation, pathognomonic eye-of-tiger sign, and disease-causing variants in PANK2 gene were identified in nearly all patients. Ten novel variants were identified expanding the genotypic spectrum of PKAN.
KW - Eye-of-the-tiger sign
KW - Movement disorders
KW - Pantothenate kinase-associated neurodegeneration
KW - Retinitis pigmentosa
UR - http://www.scopus.com/inward/record.url?scp=85153801556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85153801556&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2023.105409
DO - 10.1016/j.parkreldis.2023.105409
M3 - Article
C2 - 37121191
AN - SCOPUS:85153801556
SN - 1353-8020
VL - 111
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
M1 - 105409
ER -